| Sr No. |
|
Additional disclosure of related
party transactions - applicable only in case the related party transaction relates to loans,
inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary.
These details need to be disclosed only once, during the reporting period when such transaction was
undertaken. |
| Details of the party (listed entity/subsidiary) entering into the transaction |
Details of the counterparty |
Type of related party transaction |
Details of other related party transaction |
Value of the related party transaction as approved by the audit committee |
Remarks on approval by audit committee |
Value of the related party transaction ratified by the audit committee |
Date of Audit Committee Meeting where the ratification was approved |
Value of transaction during the reporting period |
In case monies are due to either party as a result of the transaction |
In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments |
Details of the loans, inter-corporate deposits, advances or investments |
Notes |
| Name |
PAN |
Name |
PAN |
Relationship of the counterparty with the listed entity or its subsidiary |
Opening balance |
Closing balance |
Nature of indebtedness (loan/ issuance of debt/ any other etc.) |
Details of other indebtedness |
Cost |
Tenure |
Nature (loan/ advance/ intercorporate deposit/ investment ) |
Interest Rate (%) |
Tenure |
Secured/ unsecured |
Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
5.20 |
Amount as approved by the Audit Committee. |
|
|
5.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 2 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
23,083.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 3 |
Zydus Lifesciences Limited |
|
Zydus VTEC Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
25.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,060.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
(11.40) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 6 |
Zydus Lifesciences Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 7 |
Zydus Lifesciences Limited |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
73.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 8 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
28.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 9 |
Zydus Lifesciences Limited |
|
Sterling Biotech Limited |
|
Joint Ventures |
Purchase of goods or services |
|
186.40 |
Amount as approved by the Audit Committee. |
|
|
186.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 10 |
Zydus Lifesciences Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
35.40 |
Amount as approved by the Audit Committee. |
|
|
35.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 11 |
Zydus Lifesciences Limited |
|
Oneiro Chemicals Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
3,517.90 |
Amount as approved by the Audit Committee. |
|
|
3,517.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 12 |
Zydus Lifesciences Limited |
|
Zydus VTEC Limited |
|
Subsidiary Company |
Purchase of fixed assets |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
18.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 13 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.50 |
Amount as approved by the Audit Committee. |
|
|
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 14 |
Zydus Lifesciences Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
29.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 15 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,720.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 16 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
678.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 17 |
Zydus Lifesciences Limited |
|
Zydus Medtech France SAS |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,003.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 18 |
Zydus Lifesciences Limited |
|
Zydus Medtech France SAS |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,468.70 |
2,472.30 |
|
|
|
|
|
|
|
|
|
|
| 19 |
Zydus Lifesciences Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
6.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 20 |
Zydus Lifesciences Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 21 |
Zydus Lifesciences Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
(35.80) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 22 |
Zydus Lifesciences Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
203.40 |
212.50 |
|
|
|
|
|
|
|
|
|
|
| 23 |
Zydus Lifesciences Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
63.50 |
27.90 |
|
|
|
|
|
|
|
|
|
|
| 24 |
Zydus Lifesciences Limited |
|
Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
58.70 |
Amount as approved by the Audit Committee. |
|
|
58.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 25 |
Zydus Lifesciences Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
3.60 |
Amount as approved by the Audit Committee. |
|
|
3.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 26 |
Zydus Lifesciences Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
31.30 |
Amount as approved by the Audit Committee. |
|
|
31.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 27 |
Zydus Lifesciences Limited |
|
Mukesh M. Patel & Co., Proprietorship Firm |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
55.00 |
Amount as approved by the Audit Committee. |
|
|
55.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 28 |
Zydus Lifesciences Limited |
|
International Tax & Investment Consultants-Proprietorship Firm |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
34.00 |
Amount as approved by the Audit Committee. |
|
|
34.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 29 |
Zydus Lifesciences Limited |
|
Violio Healthcare Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
990.00 |
0.00 |
990.00 |
|
|
|
|
Investment |
0 |
N.A |
Unsecured |
Business Purpose |
Textual Information(1) |
| 30 |
Zydus Lifesciences Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 31 |
Zydus Lifesciences Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
78.60 |
Amount as approved by the Audit Committee. |
|
|
78.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 32 |
Zydus Lifesciences Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
512.80 |
Amount as approved by the Audit Committee. |
|
|
512.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 33 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,372.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 34 |
Zydus Lifesciences Limited |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
396.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 35 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
498.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 36 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Mexico SA De CV |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
68.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 37 |
Zydus Lifesciences Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,373.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 38 |
Zydus Lifesciences Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
468.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 39 |
Zydus Lifesciences Limited |
|
Zydus Lanka (Private) Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
45.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 40 |
Zydus Lifesciences Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
38.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 41 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
10,190.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.800 |
5 Year |
Unsecured |
Business Purpose |
Textual Information(2) |
| 42 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
746.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 43 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
14,960.80 |
25,671.90 |
|
|
|
|
|
|
|
|
|
|
| 44 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
785.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 45 |
Zydus Lifesciences Limited |
|
Zydus Hospira Oncology Private Limited |
|
Joint Ventures |
Any other transaction |
Reimbursement of Expenses Recovered |
70.30 |
Amount as approved by the Audit Committee. |
|
|
70.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 46 |
Zydus Lifesciences Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Reimbursement of Expenses paid |
0.20 |
Amount as approved by the Audit Committee. |
|
|
0.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 47 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 48 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
11,701.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 49 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
6,645.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 50 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,70,155.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 51 |
Zydus Lifesciences Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
36,842.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 52 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Philippines Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,872.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 53 |
Zydus Lifesciences Limited |
|
Alidac Healthcare (Myanmar) Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,378.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 54 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,237.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 55 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Mexico SA De CV |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
9,292.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 56 |
Zydus Lifesciences Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,340.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 57 |
Zydus Lifesciences Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,625.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 58 |
Zydus Lifesciences Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
3,038.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 59 |
Zydus Lifesciences Limited |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,256.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 60 |
Zydus Lifesciences Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
19,307.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 61 |
Zydus Lifesciences Limited |
|
Zydus Takeda Healthcare Private Limited |
|
Joint Ventures |
Sale of goods or services |
|
577.50 |
Amount as approved by the Audit Committee. |
|
|
577.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 62 |
Zydus Lifesciences Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
277.10 |
Amount as approved by the Audit Committee. |
|
|
277.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 63 |
Zydus Lifesciences Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
20.70 |
Amount as approved by the Audit Committee. |
|
|
20.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 64 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of fixed assets |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
40.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 65 |
Zydus Lifesciences Limited |
|
Alidac Healthcare (Myanmar) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
18.70 |
18.10 |
|
|
|
|
|
|
|
|
|
|
| 66 |
Zydus Lifesciences Limited |
|
Alidac Healthcare (Myanmar) Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
498.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 67 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Sale of fixed assets |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 68 |
Zydus Lifesciences Limited |
|
Zydus Wellness Limited |
|
Subsidiary Company |
Sale of goods or services |
|
48.00 |
Amount as approved by the Audit Committee. |
|
|
48.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 69 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Sale of goods or services |
|
130.20 |
Amount as approved by the Audit Committee. |
|
|
130.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 70 |
Zydus Lifesciences Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
41.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 71 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
58.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 72 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
20.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 73 |
Zydus Lifesciences Limited |
|
Zydus VTEC Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
438.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 74 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
3,144.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 75 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
172.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 76 |
Zydus Lifesciences Limited |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
167.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 77 |
Zydus Lifesciences Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
73.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 78 |
Zydus Lifesciences Limited |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
449.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 79 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
264.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 80 |
Zydus Lifesciences Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,296.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 81 |
Zydus Lifesciences Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
12.70 |
11.60 |
|
|
|
|
|
|
|
|
|
|
| 82 |
Zydus Lifesciences Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
10,000.00 |
0.00 |
23,600.00 |
|
|
|
|
Investment |
0 |
N.A |
Unsecured |
Business Purpose |
Textual Information(3) |
| 83 |
Zydus Lifesciences Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
17.80 |
|
|
|
|
|
|
|
|
|
|
| 84 |
Zydus Lifesciences Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
11.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 85 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
276.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 86 |
Zydus Lifesciences Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1,026.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 87 |
Zydus Lifesciences Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
34,232.10 |
34,577.30 |
|
|
|
|
|
|
|
|
|
|
| 88 |
Zydus Lifesciences Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
513.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 89 |
Zydus Lifesciences Limited |
|
Zydus Wellness Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
11.50 |
Amount as approved by the Audit Committee. |
|
|
11.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 90 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
8.00 |
Amount as approved by the Audit Committee. |
|
|
8.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 91 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
115.60 |
Amount as approved by the Audit Committee. |
|
|
115.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 92 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
51.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 93 |
Zydus Lifesciences Limited |
|
Mr. Pankaj R. Patel |
|
Key Managerial Personnel |
Any other transaction |
Director Sitting Fees |
0.00 |
N.A. |
|
|
5.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 94 |
Zydus Lifesciences Limited |
|
Dr. Sharvil P. Patel |
|
Key Managerial Personnel |
Remuneration |
|
2,250.00 |
Amount as approved by the Audit Committee. |
|
|
2,250.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 95 |
Zydus Lifesciences Limited |
|
Mr. Tushar D. Shroff |
|
Key Managerial Personnel |
Remuneration |
|
196.60 |
Amount as approved by the Audit Committee. |
|
|
196.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 96 |
Zydus Lifesciences Limited |
|
Mr. Dhaval N. Soni |
|
Key Managerial Personnel |
Remuneration |
|
32.90 |
Amount as approved by the Audit Committee. |
|
|
32.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 97 |
Zydus Lifesciences Limited |
|
Dialforhealth Unity Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 98 |
Zydus Lifesciences Limited |
|
Zydus International Private Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
2,761.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 99 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
2,259.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 100 |
Zydus Lifesciences Limited |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
3,104.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 101 |
Zydus Lifesciences Limited |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
499.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 102 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
365.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 103 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
304.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 104 |
Zydus Lifesciences Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
133.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 105 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
2,755.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 106 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
10,803.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 107 |
Zydus Lifesciences Limited |
|
Zydus Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Advance for CSR |
0.00 |
N.A. |
|
|
126.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 108 |
Zydus Lifesciences Limited |
|
Zydus Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Corporate Social Responsibility (CSR) Expenses |
0.00 |
N.A. |
|
|
431.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 109 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
99,000.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 110 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,162.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 111 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
67.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 112 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
718.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 113 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
201.10 |
728.90 |
|
|
|
|
|
|
|
|
|
|
| 114 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
279.90 |
419.20 |
|
|
|
|
|
|
|
|
|
|
| 115 |
Zydus Lifesciences Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 116 |
Zydus Lifesciences Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
26.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 117 |
Zydus Lifesciences Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
31.40 |
|
|
|
|
|
|
|
|
|
|
| 118 |
Zydus Lifesciences Limited |
|
Zynext Ventures Pte. Ltd. |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
19,069.00 |
13,525.70 |
32,594.70 |
|
|
|
|
Investment |
0 |
N.A |
Unsecured |
Business Purpose |
Textual Information(4) |
| 119 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
10,231.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 120 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
52,500.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 121 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,660.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 122 |
Zydus Lifesciences Limited |
|
Cadila Healthcare Ltd. Managerial Cadre EPF |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
3,556.60 |
Amount as approved by the Audit Committee. |
|
|
3,556.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 123 |
Zydus Lifesciences Limited |
|
Cadila Healthcare Limited Employees Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
163.00 |
Amount as approved by the Audit Committee. |
|
|
163.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 124 |
Zydus Lifesciences Limited |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
11,435.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 125 |
Zydus Lifesciences Limited |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5,158.10 |
16,593.90 |
|
|
|
|
|
|
|
|
|
|
| 126 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
90,766.30 |
86,298.10 |
|
|
|
|
|
|
|
|
|
|
| 127 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
3,92,441.70 |
3,48,998.90 |
|
|
|
|
|
|
|
|
|
|
| 128 |
Zydus Lifesciences Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
4,119.40 |
4,120.50 |
|
|
|
|
|
|
|
|
|
|
| 129 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5,890.40 |
298.70 |
|
|
|
|
|
|
|
|
|
|
| 130 |
Zydus Lifesciences Limited |
|
Zydus VTEC Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
170.70 |
103.80 |
|
|
|
|
|
|
|
|
|
|
| 131 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
1,884.80 |
|
|
|
|
|
|
|
|
|
|
| 132 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
6,397.70 |
8,214.80 |
|
|
|
|
|
|
|
|
|
|
| 133 |
Zydus Lifesciences Limited |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 134 |
Zydus Lifesciences Limited |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
626.60 |
440.40 |
|
|
|
|
|
|
|
|
|
|
| 135 |
Zydus Lifesciences Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
895.90 |
905.10 |
|
|
|
|
|
|
|
|
|
|
| 136 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
9.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 137 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
3,791.20 |
1,859.50 |
|
|
|
|
|
|
|
|
|
|
| 138 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Mexico SA De CV |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
834.90 |
910.40 |
|
|
|
|
|
|
|
|
|
|
| 139 |
Zydus Lifesciences Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
982.10 |
1,031.80 |
|
|
|
|
|
|
|
|
|
|
| 140 |
Zydus Lifesciences Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
3,187.60 |
2,087.40 |
|
|
|
|
|
|
|
|
|
|
| 141 |
Zydus Lifesciences Limited |
|
Zydus Lanka (Private) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
3.00 |
45.10 |
|
|
|
|
|
|
|
|
|
|
| 142 |
Zydus Lifesciences Limited |
|
Zydus Lanka (Private) Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
6.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 143 |
Zydus Lifesciences Limited |
|
Zydus Lanka (Private) Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
43.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 144 |
Zydus Lifesciences Limited |
|
Zydus Lanka (Private) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
88.20 |
39.40 |
|
|
|
|
|
|
|
|
|
|
| 145 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
10.40 |
19.80 |
|
|
|
|
|
|
|
|
|
|
| 146 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,043.20 |
1,662.20 |
|
|
|
|
|
|
|
|
|
|
| 147 |
Zydus Lifesciences Limited |
|
Sterling Biotech Limited |
|
Joint Ventures |
Any other transaction |
Capital Advances |
4,700.00 |
Amount as approved by the Audit Committee. |
|
|
4,700.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 148 |
Zydus Lifesciences Limited |
|
Sterling Biotech Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
145.30 |
147.80 |
|
|
|
|
|
|
|
|
|
|
| 149 |
Zydus Lifesciences Limited |
|
Zydus Hospira Oncology Private Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
24.70 |
10.40 |
|
|
|
|
|
|
|
|
|
|
| 150 |
Zydus Lifesciences Limited |
|
Zydus Hospira Oncology Private Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
16.10 |
|
|
|
|
|
|
|
|
|
|
| 151 |
Zydus Lifesciences Limited |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
236.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 152 |
Zydus Lifesciences Limited |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
237.10 |
|
|
|
|
|
|
|
|
|
|
| 153 |
Zydus Lifesciences Limited |
|
Vitely Corp Pvt Ltd (Formerly Known Vitely Bio LLP) |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
9.80 |
26.80 |
|
|
|
|
|
|
|
|
|
|
| 154 |
Zydus Lifesciences Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 155 |
Zydus Lifesciences Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
32.70 |
50.20 |
|
|
|
|
|
|
|
|
|
|
| 156 |
Zydus Lifesciences Limited |
|
Oneiro Chemicals Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
662.90 |
942.40 |
|
|
|
|
|
|
|
|
|
|
| 157 |
Zydus Lifesciences Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
275.20 |
281.10 |
|
|
|
|
|
|
|
|
|
|
| 158 |
Zydus Lifesciences Limited |
|
Aleta Hospitals LLP [Formerly known as Zydus Hospitals (Vadodara) LLP] |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 159 |
Zydus Lifesciences Limited |
|
Dr. Sharvil P. Patel |
|
Key Managerial Personnel |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2,707.50 |
750.10 |
|
|
|
|
|
|
|
|
|
|
| 160 |
Zydus Lifesciences Limited |
|
Dialforhealth Unity Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
27.50 |
28.30 |
|
|
|
|
|
|
|
|
|
|
| 161 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
15,921.00 |
5,734.00 |
|
|
|
|
|
|
|
|
|
|
| 162 |
Zydus Lifesciences Limited |
|
Zydus International Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,29,474.70 |
1,32,218.60 |
|
|
|
|
|
|
|
|
|
|
| 163 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,04,280.00 |
1,05,380.00 |
|
|
|
|
|
|
|
|
|
|
| 164 |
Zydus Lifesciences Limited |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,13,760.00 |
1,14,960.00 |
|
|
|
|
|
|
|
|
|
|
| 165 |
Zydus Lifesciences Limited |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
23,416.10 |
23,912.30 |
|
|
|
|
|
|
|
|
|
|
| 166 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
3,852.00 |
2,438.20 |
|
|
|
|
|
|
|
|
|
|
| 167 |
Zydus Lifesciences Limited |
|
Zydus Wellness Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
50.30 |
60.20 |
|
|
|
|
|
|
|
|
|
|
| 168 |
Zydus Lifesciences Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
140.00 |
282.00 |
|
|
|
|
|
|
|
|
|
|
| 169 |
Zydus Lifesciences Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
124.00 |
61.00 |
|
|
|
|
|
|
|
|
|
|
| 170 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
264.40 |
197.80 |
|
|
|
|
|
|
|
|
|
|
| 171 |
Zydus Lifesciences Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
96.00 |
173.10 |
|
|
|
|
|
|
|
|
|
|
| 172 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
13,141.50 |
17,974.80 |
|
|
|
|
|
|
|
|
|
|
| 173 |
Zydus Lifesciences Limited |
|
Zydus VTEC Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
39.20 |
373.60 |
|
|
|
|
|
|
|
|
|
|
| 174 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5,90,904.80 |
4,46,101.10 |
|
|
|
|
|
|
|
|
|
|
| 175 |
Zydus Lifesciences Limited |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
149.60 |
85.80 |
|
|
|
|
|
|
|
|
|
|
| 176 |
Zydus Lifesciences Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
15,953.70 |
32,868.40 |
|
|
|
|
|
|
|
|
|
|
| 177 |
Zydus Lifesciences Limited |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
205.20 |
656.80 |
|
|
|
|
|
|
|
|
|
|
| 178 |
Zydus Lifesciences Limited |
|
Zydus Healthcare Philippines Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2,370.50 |
2,799.60 |
|
|
|
|
|
|
|
|
|
|
| 179 |
Zydus Lifesciences Limited |
|
Alidac Healthcare (Myanmar) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
987.40 |
2,379.60 |
|
|
|
|
|
|
|
|
|
|
| 180 |
Zydus Lifesciences Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
14,521.50 |
14,389.60 |
|
|
|
|
|
|
|
|
|
|
| 181 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals Mexico SA De CV |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
17,736.50 |
17,686.00 |
|
|
|
|
|
|
|
|
|
|
| 182 |
Zydus Lifesciences Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
11,716.60 |
9,140.10 |
|
|
|
|
|
|
|
|
|
|
| 183 |
Zydus Lifesciences Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
17,612.90 |
18,991.80 |
|
|
|
|
|
|
|
|
|
|
| 184 |
Zydus Lifesciences Limited |
|
Etna Biotech S.R.L. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,070.50 |
1,069.10 |
|
|
|
|
|
|
|
|
|
|
| 185 |
Zydus Lifesciences Limited |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
288.80 |
495.30 |
|
|
|
|
|
|
|
|
|
|
| 186 |
Zydus Lifesciences Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
4,313.10 |
3,290.90 |
|
|
|
|
|
|
|
|
|
|
| 187 |
Zydus Lifesciences Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
515.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 188 |
Zydus Lifesciences Limited |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
656.50 |
2,392.20 |
|
|
|
|
|
|
|
|
|
|
| 189 |
Zydus Lifesciences Limited |
|
Zydus Takeda Healthcare Private Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
804.90 |
804.90 |
|
|
|
|
|
|
|
|
|
|
| 190 |
Zydus Lifesciences Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
87.50 |
148.80 |
|
|
|
|
|
|
|
|
|
|
| 191 |
Zydus Healthcare Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
1.00 |
Amount as approved by the Audit Committee. |
|
|
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 192 |
Zydus Healthcare Limited |
|
Oneiro Chemicals Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
3.40 |
Amount as approved by the Audit Committee. |
|
|
3.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 193 |
Zydus Healthcare Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 194 |
Zydus Healthcare Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
3.20 |
Amount as approved by the Audit Committee. |
|
|
3.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 195 |
Zydus Healthcare Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of fixed assets |
|
53.10 |
Amount as approved by the Audit Committee. |
|
|
53.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 196 |
Zydus Healthcare Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
0.10 |
Amount as approved by the Audit Committee. |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 197 |
Zydus Healthcare Limited |
|
Mukesh M. Patel & Co., Proprietorship Firm |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
17.00 |
Amount as approved by the Audit Committee. |
|
|
17.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 198 |
Zydus Healthcare Limited |
|
German Remedies Pharma Private Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
739.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 199 |
Zydus Healthcare Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
510.30 |
|
|
|
|
|
|
|
|
|
|
| 200 |
Zydus Healthcare Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
587.70 |
Amount as approved by the Audit Committee. |
|
|
587.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 201 |
Zydus Healthcare Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
247.40 |
Amount as approved by the Audit Committee. |
|
|
247.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 202 |
Zydus Healthcare Limited |
|
Ramanbhai Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
8.20 |
Amount as approved by the Audit Committee. |
|
|
8.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 203 |
Zydus Healthcare Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Sale of goods or services |
|
148.00 |
Amount as approved by the Audit Committee. |
|
|
148.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 204 |
Zydus Healthcare Limited |
|
Dr. Sharvil P. Patel |
|
Key Managerial Personnel |
Any other transaction |
Director Sitting Fees |
0.00 |
N.A. |
|
|
3.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 205 |
Zydus Healthcare Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
26.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 206 |
Zydus Healthcare Limited |
|
Sterling Biotech Limited |
|
Joint Ventures |
Purchase of goods or services |
|
15.40 |
Amount as approved by the Audit Committee. |
|
|
15.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 207 |
Zydus Healthcare Limited |
|
Sterling Biotech Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
16.30 |
16.20 |
|
|
|
|
|
|
|
|
|
|
| 208 |
Zydus Healthcare Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
30.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 209 |
Zydus Healthcare Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 210 |
Zydus Healthcare Limited |
|
Zydus Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1.30 |
1.30 |
|
|
|
|
|
|
|
|
|
|
| 211 |
Zydus Healthcare Limited |
|
Zydus Lifesciences Limited |
|
Parent Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
9,500.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.9500 |
5 Year |
Unsecured |
Business Purpose |
Textual Information(5) |
| 212 |
Zydus Healthcare Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 213 |
Zydus Healthcare Limited |
|
Recon Pharmaceuticals and Investments |
|
Subsidiary Company |
Any other transaction |
Share of profit Received |
0.00 |
N.A. |
|
|
(0.50) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 214 |
Zydus Healthcare Limited |
|
Zydus Healthcare Limited Employees Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
62.50 |
Amount as approved by the Audit Committee. |
|
|
62.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 215 |
Zydus Healthcare Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.80 |
61.10 |
|
|
|
|
|
|
|
|
|
|
| 216 |
Zydus Healthcare Limited |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
9.20 |
11.10 |
|
|
|
|
|
|
|
|
|
|
| 217 |
Zydus Healthcare Limited |
|
Oneiro Chemicals Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
7.50 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 218 |
Zydus Healthcare Limited |
|
Mr. Tushar D. Shroff |
|
Key Managerial Personnel |
Any other transaction |
Director Sitting Fees |
0.00 |
N.A. |
|
|
3.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 219 |
Zydus Healthcare Limited |
|
Zydus Pharmaceuticals Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.50 |
15.20 |
|
|
|
|
|
|
|
|
|
|
| 220 |
Zydus Healthcare Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
206.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 221 |
Zydus Healthcare Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
10,000.00 |
0.00 |
0.00 |
|
|
|
|
Loan |
6.900 |
5 Year |
Unsecured |
Business Purpose |
Textual Information(6) |
| 222 |
Zydus Healthcare Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
10,185.60 |
|
|
|
|
|
|
|
|
|
|
| 223 |
Zydus Healthcare Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
20.70 |
20.70 |
|
|
|
|
|
|
|
|
|
|
| 224 |
Zydus Healthcare Limited |
|
Ramanbhai Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.80 |
2.00 |
|
|
|
|
|
|
|
|
|
|
| 225 |
Zydus Healthcare Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
67.90 |
48.60 |
|
|
|
|
|
|
|
|
|
|
| 226 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
622.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 227 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Purchase of fixed assets |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 228 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,499.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 229 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
5.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 230 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
0.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 231 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
381.80 |
413.70 |
|
|
|
|
|
|
|
|
|
|
| 232 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
2,512.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 233 |
Zydus Wellness Limited |
|
Alidac UK Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
834.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 234 |
Zydus Wellness Limited |
|
Mukesh M. Patel & Co., Proprietorship Firm |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
8.50 |
Amount as approved by the Audit Committee. |
|
|
8.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 235 |
Zydus Wellness Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
16.80 |
Amount as approved by the Audit Committee. |
|
|
16.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 236 |
Zydus Wellness Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of fixed assets |
|
0.60 |
Amount as approved by the Audit Committee. |
|
|
0.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 237 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
28,371.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 238 |
Zydus Wellness Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
377.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 239 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Sale of fixed assets |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
28.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 240 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2,414.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 241 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
500.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 242 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,200.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 243 |
Zydus Wellness Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
25.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 244 |
Zydus Wellness Limited |
|
Dr. Sharvil P. Patel |
|
Key Managerial Personnel |
Any other transaction |
Director Sitting Fees |
0.00 |
N.A. |
|
|
4.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 245 |
Zydus Lifesciences Limited |
|
Mr. Ganesh N. Nayak |
|
Key Managerial Personnel |
Remuneration |
|
186.40 |
Amount as approved by the Audit Committee. |
|
|
186.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 246 |
Zydus Wellness Limited |
|
Mr. Tarun Arora |
|
Key Managerial Personnel |
Remuneration |
|
85.40 |
Amount as approved by the Audit Committee. |
|
|
85.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 247 |
Zydus Wellness Limited |
|
Mr. Umesh V. Parikh |
|
Key Managerial Personnel |
Remuneration |
|
121.90 |
Amount as approved by the Audit Committee. |
|
|
121.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 248 |
Zydus Wellness Limited |
|
Mr. Nandish P. Joshi |
|
Key Managerial Personnel |
Remuneration |
|
11.70 |
Amount as approved by the Audit Committee. |
|
|
11.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 249 |
Zydus Wellness Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
123.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 250 |
Zydus Pharmaceuticals Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of fixed assets |
|
42.40 |
Amount as approved by the Audit Committee. |
|
|
42.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 251 |
Zydus Wellness Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 252 |
Zydus Wellness Products Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
2,360.80 |
Amount as approved by the Audit Committee. |
|
|
2,360.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 253 |
Zydus Wellness Products Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
580.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 254 |
Zydus Wellness Products Limited |
|
Apollo Healthco Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
560.90 |
654.60 |
|
|
|
|
|
|
|
|
|
|
| 255 |
Zydus Wellness Products Limited |
|
Indifoss Analytical Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
8.50 |
Amount as approved by the Audit Committee. |
|
|
8.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 256 |
Zydus Wellness Products Limited |
|
Indifoss Analytical Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of fixed assets |
|
0.90 |
Amount as approved by the Audit Committee. |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 257 |
Zydus Wellness Products Limited |
|
Indifoss Analytical Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 258 |
Zydus Wellness Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
3,792.00 |
3,832.00 |
|
|
|
|
|
|
|
|
|
|
| 259 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
12,900.00 |
17,550.20 |
|
|
|
|
|
|
|
|
|
|
| 260 |
Zydus Wellness Limited |
|
Zydus Wellness Products Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,566.90 |
5,581.40 |
|
|
|
|
|
|
|
|
|
|
| 261 |
Zydus Wellness Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
408.80 |
728.50 |
|
|
|
|
|
|
|
|
|
|
| 262 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
765.00 |
Amount as approved by the Audit Committee. |
|
|
765.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 263 |
Zydus Wellness Products Limited |
|
Mukesh M. Patel & Co., Proprietorship Firm |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
11.00 |
Amount as approved by the Audit Committee. |
|
|
11.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 264 |
Zydus Wellness Products Limited |
|
Mr. Tarun Arora |
|
Key Managerial Personnel |
Remuneration |
|
392.90 |
Amount as approved by the Audit Committee. |
|
|
392.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 265 |
Zydus Wellness Products Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,639.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 266 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of goods or services |
|
114.30 |
Amount as approved by the Audit Committee. |
|
|
114.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 267 |
Zydus Wellness Products Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
23.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 268 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of fixed assets |
|
1.10 |
Amount as approved by the Audit Committee. |
|
|
1.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 269 |
Zydus Wellness Products Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
97.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 270 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of goods or services |
|
82.50 |
Amount as approved by the Audit Committee. |
|
|
82.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 271 |
Zydus Wellness Products Limited |
|
Zydus Wellness BD Private Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
377.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 272 |
Zydus Wellness Products Limited |
|
LM Manufacturing India Private Limited |
|
Subsidiary Company |
Sale of goods or services |
|
21.00 |
Amount as approved by the Audit Committee. |
|
|
21.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 273 |
Zydus Wellness Products Limited |
|
LM Manufacturing India Private Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
3.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 274 |
Zydus Wellness Products Limited |
|
LM Manufacturing India Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.70 |
0.70 |
|
|
|
|
|
|
|
|
|
|
| 275 |
Zydus Wellness Products Limited |
|
Heinz India Private Limited Pension Fund |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
23.90 |
Amount as approved by the Audit Committee. |
|
|
23.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 276 |
Zydus Wellness Products Limited |
|
Zydus Wellness Sikkim Employees Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
8.00 |
Amount as approved by the Audit Committee. |
|
|
8.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 277 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
178.40 |
|
|
|
|
|
|
|
|
|
|
| 278 |
Zydus Wellness Products Limited |
|
Comfort Click Limited (UK) |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
413.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 279 |
Zydus Wellness Products Limited |
|
Comfort Click Limited (UK) |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
413.50 |
|
|
|
|
|
|
|
|
|
|
| 280 |
Zydus Wellness Products Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
3.80 |
Amount as approved by the Audit Committee. |
|
|
3.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 281 |
Zydus Wellness Products Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Sale of goods or services |
|
24.60 |
Amount as approved by the Audit Committee. |
|
|
24.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 282 |
Zydus Wellness Products Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 283 |
Zydus Wellness Products Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
3.90 |
19.70 |
|
|
|
|
|
|
|
|
|
|
| 284 |
Zydus Wellness Products Limited |
|
Zydus Wellness International DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2,671.80 |
4,015.50 |
|
|
|
|
|
|
|
|
|
|
| 285 |
Zydus Wellness Products Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
88.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 286 |
German Remedies Pharma Private Limited |
|
German Remedies Pharmaceuticals Private Limited Emp Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
3.00 |
Amount as approved by the Audit Committee. |
|
|
3.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 287 |
German Remedies Pharma Private Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,976.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 288 |
German Remedies Pharma Private Limited |
|
Zydus Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Sale of goods or services |
|
31.90 |
Amount as approved by the Audit Committee. |
|
|
31.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 289 |
German Remedies Pharma Private Limited |
|
Zydus Foundation |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
2.90 |
|
|
|
|
|
|
|
|
|
|
| 290 |
German Remedies Pharma Private Limited |
|
Recon Pharmaceuticals and Investments |
|
Subsidiary Company |
Any other transaction |
Share of profit Received |
0.00 |
N.A. |
|
|
(0.10) |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 291 |
German Remedies Pharma Private Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
67.70 |
|
|
|
|
|
|
|
|
|
|
| 292 |
German Remedies Pharma Private Limited |
|
Zydus Healthcare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
83.30 |
45.10 |
|
|
|
|
|
|
|
|
|
|
| 293 |
Zydus Pharmaceuticals Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
263.90 |
Amount as approved by the Audit Committee. |
|
|
263.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 294 |
Zydus Pharmaceuticals Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.50 |
2.50 |
|
|
|
|
|
|
|
|
|
|
| 295 |
Zydus Pharmaceuticals Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
6,486.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 296 |
Zydus Pharmaceuticals Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
91.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 297 |
Zydus Pharmaceuticals Limited |
|
Zydus Pharmaceuticals Limited Employees Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
1.00 |
Amount as approved by the Audit Committee. |
|
|
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 298 |
Zydus Pharmaceuticals Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,007.00 |
7,493.90 |
|
|
|
|
|
|
|
|
|
|
| 299 |
Zydus Animal Health and Investments Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
0.40 |
Amount as approved by the Audit Committee. |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 300 |
Zydus Animal Health and Investments Limited |
|
Dialforhealth Unity Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 301 |
Zydus Animal Health and Investments Limited |
|
Dialforhealth Unity Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
2.10 |
2.20 |
|
|
|
|
|
|
|
|
|
|
| 302 |
Zydus Animal Health and Investments Limited |
|
Biochem Pharmaceutical Private Limited |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 303 |
Zydus Animal Health and Investments Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1,279.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 304 |
Zydus Animal Health and Investments Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
35.00 |
Amount as approved by the Audit Committee. |
|
|
35.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 305 |
Zydus Animal Health and Investments Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
10,200.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 306 |
Zydus Animal Health and Investments Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
102.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 307 |
Zydus Animal Health and Investments Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2,375.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 308 |
Zydus Animal Health and Investments Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
2.60 |
Amount as approved by the Audit Committee. |
|
|
2.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 309 |
Zydus Animal Health and Investments Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 310 |
Zydus Animal Health and Investments Limited |
|
Zydus Infrastructure Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
11.50 |
15.20 |
|
|
|
|
|
|
|
|
|
|
| 311 |
Zydus Animal Health and Investments Limited |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
4,740.00 |
4,790.00 |
|
|
|
|
|
|
|
|
|
|
| 312 |
Zydus Animal Health and Investments Limited |
|
Zydus Medtech Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
40,389.90 |
41,151.50 |
|
|
|
|
|
|
|
|
|
|
| 313 |
Zydus Animal Health and Investments Limited |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
4,868.60 |
9,398.90 |
|
|
|
|
|
|
|
|
|
|
| 314 |
Dialforhealth Unity Limited |
|
Dialforhealth Greencross Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.10 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 315 |
Zydus Pharmaceuticals (USA) Inc. |
|
NAI Laboratories Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
535.90 |
Amount as approved by the Audit Committee. |
|
|
535.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 316 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta III, Inc |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
557.90 |
Amount as approved by the Audit Committee. |
|
|
557.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 317 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta LLC |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
5,297.50 |
Amount as approved by the Audit Committee. |
|
|
5,297.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 318 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta NV, Inc. |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
2,775.00 |
Amount as approved by the Audit Committee. |
|
|
2,775.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 319 |
Zydus Pharmaceuticals (USA) Inc. |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
5,580.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 320 |
Zydus Pharmaceuticals (USA) Inc. |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
30.80 |
|
|
|
|
|
|
|
|
|
|
| 321 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
285.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 322 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
61.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 323 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
125.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 324 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
153.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 325 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
33,845.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 326 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
4,270.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 327 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,561.20 |
4,880.60 |
|
|
|
|
|
|
|
|
|
|
| 328 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
6,289.10 |
6,708.40 |
|
|
|
|
|
|
|
|
|
|
| 329 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 330 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
105.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 331 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta LLC |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
120.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 332 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta LLC |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
5.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 333 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
9.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 334 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
12.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 335 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
1.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 336 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
9.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 337 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
9.20 |
|
|
|
|
|
|
|
|
|
|
| 338 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
97.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 339 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
0.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 340 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
475.80 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.500 |
1 Year |
Unsecured |
Business Purpose |
Textual Information(7) |
| 341 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
8.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 342 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
7.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 343 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
620.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 344 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
420.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 345 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
71.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 346 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
3,205.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 347 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
0.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 348 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
63.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 349 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
28.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 350 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,328.20 |
1,341.90 |
|
|
|
|
|
|
|
|
|
|
| 351 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Pharmaceuticals Canada Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
36.30 |
42.10 |
|
|
|
|
|
|
|
|
|
|
| 352 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
3.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 353 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
1,963.80 |
|
|
|
|
|
|
|
|
|
|
| 354 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
3.20 |
|
|
|
|
|
|
|
|
|
|
| 355 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
38,549.80 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.500 |
1 Year |
Unsecured |
Business Purpose |
Textual Information(8) |
| 356 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
15,701.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 357 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,376.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 358 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
27,881.90 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.500 |
1 Year |
Unsecured |
Business Purpose |
Textual Information(9) |
| 359 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
27,881.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 360 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
71.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 361 |
Zydus Pharmaceuticals (USA) Inc. |
|
NAI Laboratories Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
232.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 362 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta III, Inc |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,826.00 |
63.40 |
|
|
|
|
|
|
|
|
|
|
| 363 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta LLC |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
55.40 |
1,005.80 |
|
|
|
|
|
|
|
|
|
|
| 364 |
Zydus Pharmaceuticals (USA) Inc. |
|
Navinta NV, Inc. |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
141.40 |
169.20 |
|
|
|
|
|
|
|
|
|
|
| 365 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
474.40 |
671.00 |
|
|
|
|
|
|
|
|
|
|
| 366 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
33,077.60 |
17,253.00 |
|
|
|
|
|
|
|
|
|
|
| 367 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
8,039.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 368 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
21,797.30 |
13,925.10 |
|
|
|
|
|
|
|
|
|
|
| 369 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
5,360.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 370 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,34,141.00 |
1,74,356.00 |
|
|
|
|
|
|
|
|
|
|
| 371 |
Zydus Pharmaceuticals (USA) Inc. |
|
Sentynl Therapeutics Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
38.70 |
316.10 |
|
|
|
|
|
|
|
|
|
|
| 372 |
Zydus Pharmaceuticals (USA) Inc. |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
187.40 |
122.50 |
|
|
|
|
|
|
|
|
|
|
| 373 |
Zydus Pharmaceuticals (USA) Inc. |
|
ZyVet Animal Health Inc |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
115.50 |
77.90 |
|
|
|
|
|
|
|
|
|
|
| 374 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
36,428.40 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.500 |
1 Year |
Unsecured |
Business Purpose |
Textual Information(10) |
| 375 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
322.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 376 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
2,222.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 377 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
84,783.30 |
1,21,664.70 |
|
|
|
|
|
|
|
|
|
|
| 378 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 379 |
Zydus Pharmaceuticals (USA) Inc. |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
559.20 |
730.10 |
|
|
|
|
|
|
|
|
|
|
| 380 |
Zydus Worldwide DMCC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
1,904.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 381 |
Zydus Worldwide DMCC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,164.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 382 |
Zydus Worldwide DMCC |
|
Zydus Netherlands B.V. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
221.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 383 |
Zydus Worldwide DMCC |
|
Zydus Netherlands B.V. |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
13,354.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 384 |
Zydus Worldwide DMCC |
|
Zydus France, SAS |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
4,365.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 385 |
Zydus Worldwide DMCC |
|
Zydus Netherlands B.V. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
11,380.90 |
11,721.50 |
|
|
|
|
|
|
|
|
|
|
| 386 |
Zydus Worldwide DMCC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
7.80 |
1,917.30 |
|
|
|
|
|
|
|
|
|
|
| 387 |
Zydus Worldwide DMCC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
7,431.30 |
11,673.70 |
|
|
|
|
|
|
|
|
|
|
| 388 |
Zydus Therapeutics INC |
|
Zylidac Bio LLC, USA |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
14.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 389 |
Zydus Healthcare (USA) LLC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
29.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 390 |
Zydus Healthcare (USA) LLC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
219.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 391 |
Zydus Healthcare (USA) LLC |
|
Zydus Therapeutics INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
36.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 392 |
Zydus Healthcare (USA) LLC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
0.10 |
|
|
|
|
|
|
|
|
|
|
| 393 |
Zydus Healthcare (USA) LLC |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
17.30 |
17.10 |
|
|
|
|
|
|
|
|
|
|
| 394 |
ZyVet Animal Health Inc |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
167.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 395 |
ZyVet Animal Health Inc |
|
Zydus Pharmaceuticals (USA) Inc. |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,949.70 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.500 |
1 Year |
Unsecured |
Business Purpose |
Textual Information(11) |
| 396 |
Zydus Wellness International DMCC |
|
Zydus Wellness General Trading DWC LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
37.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 397 |
Zydus Wellness International DMCC |
|
Zydus Wellness General Trading DWC LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
37.30 |
|
|
|
|
|
|
|
|
|
|
| 398 |
Zydus Wellness International DMCC |
|
Zydus Wellness Trading LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
26.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 399 |
Zydus Wellness International DMCC |
|
Zydus Wellness Trading LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
26.60 |
|
|
|
|
|
|
|
|
|
|
| 400 |
Zydus Wellness International DMCC |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 401 |
Zydus Wellness International DMCC |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
6.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 402 |
Zydus Wellness International DMCC |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
1.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 403 |
Zydus Wellness International DMCC |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
12.20 |
10.70 |
|
|
|
|
|
|
|
|
|
|
| 404 |
Zydus International Private Limited |
|
RIC Chemicals LTD |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
18.60 |
Amount as approved by the Audit Committee. |
|
|
18.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 405 |
Zydus International Private Limited |
|
Zydus Netherlands B.V. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
58.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 406 |
Zydus International Private Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
52.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 407 |
Zydus International Private Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
46.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 408 |
Zydus International Private Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
55.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 409 |
Zydus International Private Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,219.20 |
0.00 |
0.00 |
|
|
|
|
Loan |
0.8500 |
5 Year |
Unsecured |
Business Purpose |
Textual Information(12) |
| 410 |
Zydus International Private Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
4,319.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 411 |
Zydus International Private Limited |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,86,215.30 |
1,90,769.80 |
|
|
|
|
|
|
|
|
|
|
| 412 |
Zydus International Private Limited |
|
Zydus Netherlands B.V. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
3,118.50 |
3,171.00 |
|
|
|
|
|
|
|
|
|
|
| 413 |
Zydus International Private Limited |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
4,416.50 |
4,461.00 |
|
|
|
|
|
|
|
|
|
|
| 414 |
Zydus International Private Limited |
|
Zydus France, SAS |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
3,016.90 |
3,057.40 |
|
|
|
|
|
|
|
|
|
|
| 415 |
Zydus International Private Limited |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
4,069.20 |
4,117.10 |
|
|
|
|
|
|
|
|
|
|
| 416 |
Zydus Netherlands B.V. |
|
Zydus Nikkho Farmaceutica Ltda. |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
13,301.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 417 |
Zydus France, SAS |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
4.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 418 |
Zydus France, SAS |
|
Laboratorios Combix S.L. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
5.20 |
|
|
|
|
|
|
|
|
|
|
| 419 |
Laboratorios Combix S.L. |
|
Zydus Pharmaceuticals UK Ltd. |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
3.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 420 |
Zydus Healthcare S.A. (Pty) Ltd |
|
DI Consultancy |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
154.90 |
Amount as approved by the Audit Committee. |
|
|
154.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 421 |
Zydus Healthcare S.A. (Pty) Ltd |
|
Alidac Pharmaceuticals SA (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
4,995.80 |
5,285.10 |
|
|
|
|
|
|
|
|
|
|
| 422 |
Zydus Healthcare S.A. (Pty) Ltd |
|
Alidac Pharmaceuticals SA (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
606.90 |
641.90 |
|
|
|
|
|
|
|
|
|
|
| 423 |
Script Management Services (Pty) Ltd |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4,920.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 424 |
Script Management Services (Pty) Ltd |
|
Zydus Healthcare S.A. (Pty) Ltd |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
245.40 |
1,424.10 |
|
|
|
|
|
|
|
|
|
|
| 425 |
Zydus Healthcare Philippines Inc. |
|
RJ Conception Law Office |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
0.90 |
Amount as approved by the Audit Committee. |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 426 |
Alidac Healthcare (Myanmar) Limited |
|
Cadmach Machinery Company Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
2.00 |
|
|
|
|
|
|
|
|
|
|
| 427 |
Zynext Ventures Pte. Ltd. |
|
Zynext Ventures USA LLC |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
19,032.00 |
12,587.00 |
31,619.00 |
|
|
|
|
Investment |
0 |
N.A |
Unsecured |
Business Purpose |
Textual Information(13) |
| 428 |
Zydus Pharmaceuticals UK Ltd. |
|
LiqMeds Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
172.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 429 |
Zydus Pharmaceuticals UK Ltd. |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
0.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 430 |
Zydus Pharmaceuticals UK Ltd. |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,072.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 431 |
Zydus Pharmaceuticals UK Ltd. |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
305.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 432 |
Zydus Pharmaceuticals UK Ltd. |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
38.80 |
364.60 |
|
|
|
|
|
|
|
|
|
|
| 433 |
Zydus Pharmaceuticals UK Ltd. |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
5,054.60 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 434 |
Zydus Pharmaceuticals UK Ltd. |
|
LiqMeds Limited |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
8,868.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 435 |
Zydus Pharmaceuticals UK Ltd. |
|
LiqMeds Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
8,945.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 436 |
Zydus Lifesciences Global FZE [UAE] |
|
Zydus Lifesciences Limited |
|
Parent Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
54,920.60 |
58,774.70 |
|
|
|
|
|
|
|
|
|
|
| 437 |
Zydus Lifesciences Global FZE [UAE] |
|
Zydus Worldwide DMCC |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
475.10 |
495.30 |
|
|
|
|
|
|
|
|
|
|
| 438 |
Zydus Lifesciences Global FZE [UAE] |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
6,368.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 439 |
Zydus Lifesciences Global FZE [UAE] |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
224.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 440 |
Zydus Lifesciences Global FZE [UAE] |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
263.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 441 |
Zydus Lifesciences Global FZE [UAE] |
|
Zydus Healthcare (USA) LLC |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
36.20 |
98.40 |
|
|
|
|
|
|
|
|
|
|
| 442 |
Zydus Lifesciences Global FZE [UAE] |
|
Viona Pharmaceuticals INC |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2,792.90 |
3,669.40 |
|
|
|
|
|
|
|
|
|
|
| 443 |
LiqMeds Worldwide Limited |
|
LiqMeds Lifecare Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
207.10 |
210.40 |
|
|
|
|
|
|
|
|
|
|
| 444 |
LiqMeds Worldwide Limited |
|
LiqMeds Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
731.50 |
743.40 |
|
|
|
|
|
|
|
|
|
|
| 445 |
LM Manufacturing Limited |
|
LiqMeds Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
1,069.30 |
|
|
|
|
|
|
|
|
|
|
| 446 |
LM Manufacturing India Private Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
382.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 447 |
LiqMeds Worldwide Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
40,019.50 |
56,724.30 |
|
|
|
|
|
|
|
|
|
|
| 448 |
LM Manufacturing Limited |
|
Medsolutions (Europe) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
18.60 |
18.90 |
|
|
|
|
|
|
|
|
|
|
| 449 |
LM Manufacturing Limited |
|
Oncosol Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
32.70 |
16.60 |
|
|
|
|
|
|
|
|
|
|
| 450 |
LiqMeds Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
7,281.70 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 451 |
LiqMeds Lifecare Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,264.50 |
1,285.10 |
|
|
|
|
|
|
|
|
|
|
| 452 |
LM Manufacturing India Private Limited |
|
LM Manufacturing Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
78.40 |
59.20 |
|
|
|
|
|
|
|
|
|
|
| 453 |
LiqMeds Lifecare Limited |
|
LiqMeds Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
11.20 |
11.40 |
|
|
|
|
|
|
|
|
|
|
| 454 |
LiqMeds Lifecare Limited |
|
Medsolutions (Europe) Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
112.60 |
114.40 |
|
|
|
|
|
|
|
|
|
|
| 455 |
LiqMeds Lifecare Limited |
|
Oncosol Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
359.20 |
1,250.10 |
|
|
|
|
|
|
|
|
|
|
| 456 |
Medsolutions (Europe) Limited |
|
LiqMeds Worldwide Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
144.60 |
146.90 |
|
|
|
|
|
|
|
|
|
|
| 457 |
Medsolutions (Europe) Limited |
|
Oncosol Limited |
|
Joint Ventures |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5.40 |
5.50 |
|
|
|
|
|
|
|
|
|
|
| 458 |
Zydus Medtech Private Limited |
|
Zydus Medtech France SAS |
|
Subsidiary Company |
Investment |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 459 |
Zydus Medtech Private Limited |
|
Zydus Medtech Private Ltd. Employees Group Gratuity Scheme |
|
Post Employment Benefit Plans |
Any other transaction |
Contributions during the year [includes Employee's share and contribution] |
52.00 |
Amount as approved by the Audit Committee. |
|
|
52.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 460 |
Zydus Medtech Private Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
0.40 |
|
|
|
|
|
|
|
|
|
|
| 461 |
Zydus Medtech Private Limited |
|
Zydus Hospitals and Healthcare Research Private Limited |
|
Enterprises significantly influenced by Directors and/ or their relatives |
Purchase of goods or services |
|
0.40 |
Amount as approved by the Audit Committee. |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 462 |
German Remedies Pharma Private Limited |
|
Zydus Animal Health and Investments Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
0.50 |
|
|
|
|
|
|
|
|
|
|
| 463 |
Zydus Worldwide DMCC |
|
Zydus Lifesciences Global FZE [UAE] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
15.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 464 |
Zydus Medtech France SAS |
|
Amplitude Surgical SAS |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1,514.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 465 |
Zydus Medtech France SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5,642.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 466 |
Zydus Medtech France SAS |
|
Amplitude Surgical SAS |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
79,382.20 |
79,251.40 |
|
|
|
|
|
|
|
|
|
|
| 467 |
Zydus Medtech France SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
63.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 468 |
Zydus Medtech France SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
6,258.10 |
678.80 |
|
|
|
|
|
|
|
|
|
|
| 469 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
641.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 470 |
Amplitude SAS [France] |
|
SCI SOFAB FALLA [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
317.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 471 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,262.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 472 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
778.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 473 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
607.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 474 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
790.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 475 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,019.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 476 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,270.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 477 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
331.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 478 |
Amplitude SAS [France] |
|
Amplitude Latin America SA [Brazil] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,823.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 479 |
Amplitude SAS [France] |
|
Amplitude Benelux [Belgium] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,171.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 480 |
Amplitude SAS [France] |
|
Amplitude Suisse SA [Switzerland] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
128.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 481 |
Amplitude SAS [France] |
|
Amplitude GmbH [Germany] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
103.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 482 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
67.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 483 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
16.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 484 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
5.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 485 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
16.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 486 |
Amplitude SAS [France] |
|
Amplitude Benelux [Belgium] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
211.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 487 |
Amplitude SAS [France] |
|
Amplitude Orthopedics Corporation [USA] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
71.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 488 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
3.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 489 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
59.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 490 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
230.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 491 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
84.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 492 |
Amplitude SAS [France] |
|
Amplitude Benelux [Belgium] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
36.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 493 |
Amplitude SAS [France] |
|
Amplitude Suisse SA [Switzerland] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 494 |
Amplitude SAS [France] |
|
Amplitude Suisse SA [Switzerland] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
13.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 495 |
Amplitude SAS [France] |
|
Amplitude GmbH [Germany] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
17.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 496 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
57.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 497 |
Amplitude SAS [France] |
|
SCI SOFAB FALLA [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
1.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 498 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
3.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 499 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 500 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
9.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 501 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
4.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 502 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
4.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 503 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
15.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 504 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
3.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 505 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
433.20 |
|
|
|
|
|
|
|
|
|
|
| 506 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
3.70 |
|
|
|
|
|
|
|
|
|
|
| 507 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
108.80 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 508 |
Amplitude SAS [France] |
|
Amplitude New Zealand, New Zealand |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
311.10 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 509 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
3,467.90 |
3,867.00 |
|
|
|
|
|
|
|
|
|
|
| 510 |
Amplitude SAS [France] |
|
SCI SOFAB FALLA [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
102.30 |
104.20 |
|
|
|
|
|
|
|
|
|
|
| 511 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
174.00 |
250.30 |
|
|
|
|
|
|
|
|
|
|
| 512 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
13.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 513 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 514 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
0.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 515 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
86.70 |
|
|
|
|
|
|
|
|
|
|
| 516 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
5.20 |
|
|
|
|
|
|
|
|
|
|
| 517 |
Amplitude SAS [France] |
|
Aptitude Orthopedie [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
2.60 |
|
|
|
|
|
|
|
|
|
|
| 518 |
Amplitude SAS [France] |
|
FBC Medical [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
377.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 519 |
Amplitude SAS [France] |
|
FBC Medical [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 520 |
Amplitude SAS [France] |
|
FBC Medical [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
280.00 |
|
|
|
|
|
|
|
|
|
|
| 521 |
Amplitude SAS [France] |
|
FBC Medical [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
2.80 |
|
|
|
|
|
|
|
|
|
|
| 522 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
803.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 523 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 524 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Interest paid |
|
0.00 |
N.A. |
|
|
8.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 525 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
407.90 |
452.50 |
|
|
|
|
|
|
|
|
|
|
| 526 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
380.70 |
480.70 |
|
|
|
|
|
|
|
|
|
|
| 527 |
Amplitude SAS [France] |
|
Mediconseil |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
5.40 |
4.70 |
|
|
|
|
|
|
|
|
|
|
| 528 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 529 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
12.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 530 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
277.40 |
|
|
|
|
|
|
|
|
|
|
| 531 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
505.80 |
696.40 |
|
|
|
|
|
|
|
|
|
|
| 532 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
194.70 |
514.20 |
|
|
|
|
|
|
|
|
|
|
| 533 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Loans |
0.00 |
N.A. |
|
|
0.00 |
249.10 |
253.10 |
|
|
|
|
|
|
|
|
|
|
| 534 |
Amplitude SAS [France] |
|
Amplitude Latin America SA [Brazil] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
34.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 535 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
28.30 |
105.00 |
|
|
|
|
|
|
|
|
|
|
| 536 |
Amplitude SAS [France] |
|
SCI SOFAB FALLA [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
134.70 |
|
|
|
|
|
|
|
|
|
|
| 537 |
Amplitude SAS [France] |
|
SCI SOFAB FALLA [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
50.00 |
209.70 |
|
|
|
|
|
|
|
|
|
|
| 538 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
738.60 |
466.40 |
|
|
|
|
|
|
|
|
|
|
| 539 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
324.20 |
305.40 |
|
|
|
|
|
|
|
|
|
|
| 540 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
357.90 |
236.90 |
|
|
|
|
|
|
|
|
|
|
| 541 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
461.20 |
309.60 |
|
|
|
|
|
|
|
|
|
|
| 542 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
517.80 |
473.10 |
|
|
|
|
|
|
|
|
|
|
| 543 |
Amplitude SAS [France] |
|
Amplitude Orthopedics Corporation [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
6,851.00 |
7,044.30 |
|
|
|
|
|
|
|
|
|
|
| 544 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
22,479.40 |
23,405.00 |
|
|
|
|
|
|
|
|
|
|
| 545 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
2.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 546 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,539.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 547 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
5,069.10 |
4,099.90 |
|
|
|
|
|
|
|
|
|
|
| 548 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
16.10 |
|
|
|
|
|
|
|
|
|
|
| 549 |
Amplitude SAS [France] |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
233.90 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 550 |
Amplitude SAS [France] |
|
Amplitude Benelux [Belgium] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
2,338.80 |
2,262.30 |
|
|
|
|
|
|
|
|
|
|
| 551 |
Amplitude SAS [France] |
|
Amplitude Suisse SA [Switzerland] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,451.10 |
1,356.00 |
|
|
|
|
|
|
|
|
|
|
| 552 |
Amplitude SAS [France] |
|
Amplitude GmbH [Germany] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
0.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 553 |
Amplitude SAS [France] |
|
Amplitude GmbH [Germany] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
1,107.40 |
1,051.90 |
|
|
|
|
|
|
|
|
|
|
| 554 |
Amplitude SAS [France] |
|
Amplitude Australia Pty Ltd [Australia] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
872.40 |
617.10 |
|
|
|
|
|
|
|
|
|
|
| 555 |
Amplitude SAS [France] |
|
Amplitude South Africa Pty Ltd [South Africa] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
140.30 |
100.10 |
|
|
|
|
|
|
|
|
|
|
| 556 |
Amplitude SAS [France] |
|
Amplitude Latin America SA [Brazil] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
6,013.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 557 |
Amplitude SAS [France] |
|
Amplitude Ile de France [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
45.70 |
44.90 |
|
|
|
|
|
|
|
|
|
|
| 558 |
Amplitude SAS [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
4.40 |
3.80 |
|
|
|
|
|
|
|
|
|
|
| 559 |
Amplitude SAS [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
15.30 |
6.20 |
|
|
|
|
|
|
|
|
|
|
| 560 |
Amplitude SAS [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
15.20 |
3.80 |
|
|
|
|
|
|
|
|
|
|
| 561 |
Amplitude SAS [France] |
|
Ortho Santé (Amplitude Ouest) [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
43.50 |
34.40 |
|
|
|
|
|
|
|
|
|
|
| 562 |
Amplitude SAS [France] |
|
Amplitude Benelux [Belgium] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
644.00 |
655.10 |
|
|
|
|
|
|
|
|
|
|
| 563 |
Amplitude SAS [France] |
|
Amplitude Suisse SA [Switzerland] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
105.50 |
50.60 |
|
|
|
|
|
|
|
|
|
|
| 564 |
Amplitude SAS [France] |
|
Amplitude GmbH [Germany] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
95.70 |
24.60 |
|
|
|
|
|
|
|
|
|
|
| 565 |
Amplitude Surgical SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,327.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 566 |
Amplitude Surgical SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Loan |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
31,038.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 567 |
Amplitude Surgical SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1,345.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 568 |
Amplitude Surgical SAS |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
48.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 569 |
Amplitude Surgical SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.40 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 570 |
Amplitude Surgical SAS |
|
Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
38,706.10 |
7,408.80 |
|
|
|
|
|
|
|
|
|
|
| 571 |
Amplitude Surgical SAS |
|
SCI Les Tilleuls [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
2,760.30 |
3,217.20 |
|
|
|
|
|
|
|
|
|
|
| 572 |
Amplitude Ile de France [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4.70 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 573 |
Amplitude Ile de France [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
4.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 574 |
Amplitude Ile de France [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
9.20 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 575 |
Amplitude Ile de France [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
9.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 576 |
Amplitude Ile de France [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
4.00 |
5.90 |
|
|
|
|
|
|
|
|
|
|
| 577 |
Amplitude Ile de France [France] |
|
Duotech Amplitude SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.70 |
2.80 |
|
|
|
|
|
|
|
|
|
|
| 578 |
Amplitude Ile de France [France] |
|
Amplitude Sud SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.80 |
2.90 |
|
|
|
|
|
|
|
|
|
|
| 579 |
Amplitude Ile de France [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Purchase of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
20.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 580 |
Amplitude Ile de France [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
4.90 |
8.80 |
|
|
|
|
|
|
|
|
|
|
| 581 |
Amplitude Ile de France [France] |
|
Amplitude Nord SAS [France] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
2.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 582 |
Comfort Click Limited (Ireland) |
|
Comfort Click Limited (UK) |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
17,216.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 583 |
Comfort Click Softech Pvt. Ltd. |
|
Comfort Click Limited (UK) |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
1,846.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 584 |
Comfort Click Limited (UK) |
|
Comfort Click Limited (Ireland) |
|
Subsidiary Company |
Sale of goods or services |
|
0.00 |
Transaction with wholly owned subsidiary; Audit committee approval is not required as per applicable laws. |
|
|
119.40 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 585 |
Comfort Click Limited (UK) |
|
Comfort Click Limited (Ireland) |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses paid |
0.00 |
N.A. |
|
|
126.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 586 |
Comfort Click Limited (UK) |
|
Comfort Click Limited (Ireland) |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
1,373.40 |
1,379.50 |
|
|
|
|
|
|
|
|
|
|
| 587 |
Alidac UK Limited |
|
Comfort Click Limited (UK) |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
1.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 588 |
Comfort Click Limited (UK) |
|
Comfort Click LLC (USA) |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 589 |
Comfort Click Limited (UK) |
|
Comfort Click LLC (USA) |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
41.00 |
|
|
|
|
|
|
|
|
|
|
| 590 |
Comfort Click Limited (UK) |
|
Zydus Wellness (EU) Limited [Ireland] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
6.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 591 |
Comfort Click Limited (UK) |
|
Zydus Wellness (EU) Limited [Ireland] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
6.50 |
|
|
|
|
|
|
|
|
|
|
| 592 |
Comfort Click Limited (UK) |
|
Comfort Click Softech Pvt. Ltd. |
|
Subsidiary Company |
Any other transaction |
Outstanding Payables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
303.30 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 593 |
Assertio Management LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
4,155.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 594 |
Zyla Life Sciences US LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
21,688.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 595 |
Zyla Life Sciences US LLC [USA] |
|
Zyla Life Sciences Limited [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
4,899.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 596 |
Zyla Life Sciences US LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
21,689.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 597 |
Assertio Distribution LLC [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
14,274.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 598 |
Assertio Management LLC [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
14.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 599 |
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
7,666.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 600 |
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2,750.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 601 |
Assertio Distribution LLC [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
10,106.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 602 |
Asio Holdings LLC [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
471.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 603 |
Assertio Distribution LLC [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2,279.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 604 |
Spectrum Pharmaceuticals Inc. [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
1,051.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 605 |
Assertio Distribution LLC [USA] |
|
Spectrum Pharmaceuticals Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
578.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 606 |
Assertio Distribution LLC [USA] |
|
Spectrum Pharmaceuticals Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
579.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 607 |
Assertio Distribution LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
6,918.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 608 |
Assertio Distribution LLC [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
14,274.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 609 |
Assertio Distribution LLC [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
10,106.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 610 |
Assertio Distribution LLC [USA] |
|
Asio Holdings LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2,279.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 611 |
Assertio Management LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
101.80 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 612 |
Assertio Management LLC [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
14.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 613 |
Assertio Management LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
4,051.90 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 614 |
Assertio Distribution LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
6,917.20 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 615 |
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
7,666.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 616 |
Spectrum Pharmaceuticals Inc. [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
1,051.50 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 617 |
Asio Holdings LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Reimbursement of Expenses Recovered |
0.00 |
N.A. |
|
|
2,750.10 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 618 |
Zyla Life Sciences Limited [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
2,472.30 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 619 |
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Interest received |
|
0.00 |
N.A. |
|
|
1,875.60 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
| 620 |
Assertio Holdings Inc. [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
49,328.30 |
|
|
|
|
|
|
|
|
|
|
| 621 |
Assertio Management LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
102.20 |
|
|
|
|
|
|
|
|
|
|
| 622 |
Zyla Life Sciences US LLC [USA] |
|
Assertio Holdings Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
61,579.40 |
|
|
|
|
|
|
|
|
|
|
| 623 |
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Assertio Distribution LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
10,291.00 |
|
|
|
|
|
|
|
|
|
|
| 624 |
Zyla Life Sciences US LLC [USA] |
|
Zyla Life Sciences Limited [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
1,29,335.70 |
|
|
|
|
|
|
|
|
|
|
| 625 |
Zyla Life Sciences Limited [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
2,27,177.10 |
|
|
|
|
|
|
|
|
|
|
| 626 |
Assertio Management LLC [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
56,184.90 |
|
|
|
|
|
|
|
|
|
|
| 627 |
Assertio Management LLC [USA] |
|
Spectrum Pharmaceuticals Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
28,795.30 |
|
|
|
|
|
|
|
|
|
|
| 628 |
Assertio Distribution LLC [USA] |
|
Spectrum Pharmaceuticals Inc. [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
583.40 |
|
|
|
|
|
|
|
|
|
|
| 629 |
Spectrum Pharmaceuticals Inc. [USA] |
|
Spectrum Oncology Private Limited |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
121.10 |
|
|
|
|
|
|
|
|
|
|
| 630 |
Assertio Management LLC [USA] |
|
Asio Holdings LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
4,794.90 |
|
|
|
|
|
|
|
|
|
|
| 631 |
Assertio Distribution LLC [USA] |
|
Asio Holdings LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
1,148.00 |
|
|
|
|
|
|
|
|
|
|
| 632 |
Assertio Distribution LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
468.40 |
|
|
|
|
|
|
|
|
|
|
| 633 |
Assertio Distribution LLC [USA] |
|
Zyla Life Sciences US LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
744.20 |
|
|
|
|
|
|
|
|
|
|
| 634 |
Zyla Life Sciences US LLC [USA] |
|
Assertio Management LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Other than loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
22,164.60 |
|
|
|
|
|
|
|
|
|
|
| 635 |
Assertio Holdings Inc. [USA] |
|
Zyla Life Sciences Limited [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
74,565.40 |
|
|
|
|
|
|
|
|
|
|
| 636 |
Assertio Holdings Inc. [USA] |
|
Assertio Specialty Pharmaceuticals LLC [USA] |
|
Subsidiary Company |
Any other transaction |
Outstanding Receivables - Loans |
0.00 |
N.A. |
|
|
0.00 |
0.00 |
56,571.90 |
|
|
|
|
|
|
|
|
|
|
|
Total value of transaction during the reporting period |
11,88,028.40 |
|
|